Table 2.
Subgroups | Categories | Drug-responsive patients |
Drug-resistant
patients |
OR
(95% CI ) |
P |
---|---|---|---|---|---|
Patient age in years (Mean ± SD) | 27 ± 13 | 28.8 ± 11 | - | 0.19 | |
Patient age groups | <12 years >12 years |
10 (5%) 190 (95%) |
4 (3%) 128 (97%) |
1.68 (0.52-5.48) 1 |
0.39 |
Gender | Male Female |
96 (48%) 104 (52%) |
79 (59.8%) 53 (40.2%) |
1.62 (1.03-2.52) 1 |
0.04 |
Type of seizure | Complex partial | 1 (0.5%) | 0 | ||
Generalized tonic-clonic | 199 (99.5%) | 0 | |||
Generalized tonic-clonic + complex partial | 0 | 118 (89.4%) | |||
Generalized tonic-clonic + partial | 0 | 14 (10.6%) | |||
Type of epilepsy | Complex partial | 122 (61%) | 126 (95.5%) | 13.08 (5.49-31.16) | <0.001 |
Generalized tonic-clonic | 76 (38%) | 6 (4.5%) | 1 | ||
Juvenile myoclonic | 2 (1%) | 0 | |||
Etiology of epilepsy | Idiopathic Symptomatic |
78 (59%) 122 (61%) |
6 (4.5%) 126 (95.5%) |
13.43 (5.64-31.92) 1 |
<0.001 |
Number of dministered antiepileptic drugs | 1 2 3 4 5 |
191 (99.5%) 9 (0.5%) 0 0 0 |
0 18 (13.6%) 88 (66.6%) 25 (18.9%) 1 (0.8%) |
OR, odds ratios; CI, confidence interva